NPI: 1437171568 · LUBBOCK, TX 79410 · Ambulatory Surgical Clinic/Center · NPI assigned 07/25/2006
Authorized official ANDERSON, DONALD controls 20+ related entities in our dataset. Read more
| Authorized Official | ANDERSON, DONALD (ASSISTANT SECRETARY OF ENROLLMENTS) |
| NPI Enumeration Date | 07/25/2006 |
Other providers sharing the same authorized official: ANDERSON, DONALD
| Year | Claims | Total Paid |
|---|---|---|
| 2018 | 1,021 | $20K |
| 2019 | 961 | $15K |
| 2020 | 2,905 | $200K |
| 2021 | 29,347 | $2.53M |
| 2022 | 46,982 | $3.82M |
| 2023 | 48,394 | $3.85M |
| 2024 | 34,315 | $2.25M |
| Code | Description | Claims | Beneficiaries | Total Paid |
|---|---|---|---|---|
| 99284 | Emergency department visit for the evaluation and management, high severity | 8,416 | 8,161 | $2.93M |
| 99283 | Emergency department visit for the evaluation and management, moderate severity | 25,312 | 24,780 | $2.17M |
| 11042 | Debridement, subcutaneous tissue (includes epidermis, dermis, and subcutaneous tissue); first 20 sq cm | 3,337 | 1,398 | $1.36M |
| G0378 | Hospital observation service, per hour | 1,858 | 1,139 | $1.01M |
| 99285 | Emergency department visit for the evaluation and management, high severity with immediate threat to life | 1,854 | 1,819 | $979K |
| 41899 | Unlisted procedure, dentoalveolar structures | 378 | 274 | $548K |
| 99282 | Emergency department visit for the evaluation and management, low to moderate severity | 3,532 | 3,443 | $278K |
| 99281 | Emergency department visit for the evaluation and management, self-limited or minor | 3,205 | 3,174 | $254K |
| 85025 | Blood count; complete (CBC), automated, and automated differential WBC count | 19,545 | 16,670 | $228K |
| 42820 | Tonsillectomy and adenoidectomy; younger than age 12 | 72 | 71 | $209K |
| 80053 | Comprehensive metabolic panel | 12,769 | 10,951 | $204K |
| 96413 | Chemotherapy administration, intravenous infusion; up to 1 hour, single or initial substance | 842 | 512 | $199K |
| 87389 | Infectious agent antigen detection by immunoassay technique, HIV-1 antigen with HIV-1 and HIV-2 antibodies | 3,089 | 3,028 | $154K |
| 87502 | Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets | 1,342 | 1,310 | $153K |
| G0463 | Hospital outpatient clinic visit for assessment and management of a patient | 4,795 | 4,204 | $135K |
| 76770 | 539 | 513 | $133K | |
| 86780 | 3,193 | 3,053 | $85K | |
| 97530 | Therapeutic activities, direct patient contact, each 15 minutes | 1,888 | 597 | $80K |
| U0002 | 2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc | 2,915 | 2,814 | $79K |
| 36415 | Collection of venous blood by venipuncture | 15,770 | 13,653 | $78K |
| 99212 | Office or other outpatient visit for the evaluation and management of an established patient, straightforward | 471 | 390 | $74K |
| 84443 | Thyroid stimulating hormone (TSH) | 2,201 | 2,133 | $70K |
| 92507 | Treatment of speech, language, voice, communication, and/or auditory processing disorder | 605 | 178 | $69K |
| 94640 | Pressurized or nonpressurized inhalation treatment for acute airway obstruction | 577 | 511 | $62K |
| 84702 | 2,114 | 1,722 | $58K | |
| 96375 | Therapeutic injection; each additional sequential IV push | 947 | 597 | $58K |
| 0202U | Oncology (prostate), multianalyte, gene expression profiling | 493 | 484 | $52K |
| 82306 | Vitamin D; 25 hydroxy, includes fraction(s), if performed | 773 | 762 | $41K |
| 86762 | 1,281 | 1,247 | $37K | |
| 36591 | 867 | 563 | $36K | |
| 96365 | Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour | 367 | 299 | $36K |
| 87651 | Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe | 841 | 831 | $36K |
| 86850 | 1,941 | 1,842 | $35K | |
| 87340 | 1,651 | 1,616 | $34K | |
| 69436 | Tympanostomy (requiring insertion of ventilating tube), general anesthesia | 27 | 26 | $34K |
| 71046 | Radiologic examination, chest; 2 views | 792 | 783 | $33K |
| 87591 | Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe | 444 | 433 | $28K |
| 87491 | Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe | 445 | 434 | $28K |
| 86803 | 801 | 778 | $26K | |
| 87635 | Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe | 531 | 526 | $26K |
| 93005 | Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report | 463 | 446 | $25K |
| 0353U | 711 | 683 | $25K | |
| 87086 | Culture, bacterial; quantitative colony count, urine | 1,586 | 1,544 | $24K |
| 87880 | Infectious agent antigen detection by immunoassay; Streptococcus, group A | 1,572 | 1,544 | $24K |
| 88305 | Level IV - Surgical pathology, gross and microscopic examination | 191 | 174 | $24K |
| 43239 | Esophagogastroduodenoscopy, flexible, transoral; with biopsy, single or multiple | 40 | 37 | $19K |
| 74018 | 385 | 351 | $19K | |
| 80061 | Lipid panel | 648 | 647 | $17K |
| 86900 | 1,877 | 1,767 | $17K | |
| J1100 | Injection, dexamethasone sodium phosphate, 1 mg | 2,149 | 1,743 | $15K |
| 96372 | Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular | 400 | 335 | $15K |
| 80307 | Drug test(s), presumptive, any number of drug classes; immunoassay | 297 | 285 | $15K |
| J2405 | Injection, ondansetron hydrochloride, per 1 mg | 1,891 | 1,404 | $15K |
| 82950 | 1,181 | 1,174 | $14K | |
| D2930 | Prefabricated stainless steel crown - primary tooth | 12 | 12 | $14K |
| 96374 | Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance | 493 | 463 | $14K |
| 70551 | Magnetic resonance imaging, brain; without contrast material | 43 | 43 | $13K |
| 86705 | 450 | 447 | $13K | |
| 84439 | 888 | 864 | $13K | |
| 83655 | 447 | 445 | $13K | |
| 86787 | 413 | 403 | $12K | |
| 86901 | 1,858 | 1,753 | $11K | |
| 83036 | Hemoglobin; glycosylated (A1C) | 460 | 456 | $9K |
| 96367 | 154 | 90 | $9K | |
| 84144 | 191 | 143 | $9K | |
| 81001 | 1,648 | 1,585 | $8K | |
| 86140 | 925 | 876 | $7K | |
| J0561 | Injection, penicillin g benzathine, 100,000 units | 32 | 32 | $7K |
| 88313 | 65 | 51 | $6K | |
| J1642 | Injection, heparin sodium, (heparin lock flush), per 10 units | 518 | 256 | $6K |
| 85027 | 350 | 333 | $6K | |
| 87798 | Infectious agent detection by nucleic acid; not otherwise specified, amplified probe, each organism | 218 | 216 | $5K |
| 97110 | Therapeutic procedure, each 15 minutes; therapeutic exercises to develop strength and endurance, flexibility and range of motion | 46 | 14 | $5K |
| 83615 | 799 | 718 | $5K | |
| 99220 | 24 | 24 | $5K | |
| 80050 | General health panel | 46 | 42 | $5K |
| 81002 | 742 | 618 | $4K | |
| 82728 | 326 | 296 | $4K | |
| 86300 | 166 | 154 | $4K | |
| 81000 | 598 | 555 | $3K | |
| 88342 | 61 | 51 | $3K | |
| U0003 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r | 38 | 38 | $3K |
| J2704 | Injection, propofol, 10 mg | 701 | 634 | $3K |
| 88312 | 49 | 37 | $3K | |
| 71045 | Radiologic examination, chest; single view | 56 | 56 | $3K |
| 76705 | Ultrasound, abdominal, real time with image documentation; limited | 14 | 13 | $3K |
| 87804 | Infectious agent antigen detection by immunoassay; Influenza, each type | 170 | 80 | $3K |
| U0005 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within 2 calendar days from date of specimen collection (list separately in addition to either hcpcs code u0003 or u0004) as described by cms-2020-01-r2 | 169 | 158 | $3K |
| 96417 | 21 | 12 | $3K | |
| 76817 | Ultrasound, pregnant uterus, real time with image documentation, transvaginal | 30 | 26 | $2K |
| J3490 | Unclassified drugs | 55 | 53 | $2K |
| 87070 | 353 | 346 | $2K | |
| 74019 | 39 | 39 | $2K | |
| 81025 | 270 | 257 | $2K | |
| 70450 | Computed tomography, head or brain; without contrast material | 15 | 15 | $2K |
| 96361 | Intravenous infusion, hydration; each additional hour | 18 | 16 | $2K |
| J0690 | Injection, cefazolin sodium, 500 mg | 334 | 256 | $2K |
| 81003 | 482 | 475 | $2K | |
| 71260 | Computed tomography, thorax, diagnostic; with contrast material | 13 | 13 | $2K |
| 83550 | 186 | 181 | $2K | |
| 97112 | Therapeutic procedure, each 15 minutes; neuromuscular reeducation of movement, balance, coordination | 24 | 12 | $2K |
| J2270 | Injection, morphine sulfate, up to 10 mg | 156 | 112 | $1K |
| 86706 | 53 | 52 | $1K | |
| 83540 | 202 | 196 | $1K | |
| J3010 | Injection, fentanyl citrate, 0.1 mg | 119 | 118 | $1K |
| 90834 | Psychotherapy, 45 minutes with patient | 56 | 30 | $990.63 |
| J1885 | Injection, ketorolac tromethamine, per 15 mg | 130 | 89 | $989.20 |
| 87040 | 89 | 86 | $944.66 | |
| 82570 | 96 | 71 | $923.19 | |
| 87634 | 13 | 13 | $881.62 | |
| 96376 | 17 | 12 | $815.60 | |
| 77067 | Screening mammography, bilateral, including computer-aided detection | 36 | 36 | $809.88 |
| 82784 | 71 | 64 | $804.51 | |
| 87807 | 84 | 84 | $767.85 | |
| 86364 | 24 | 24 | $725.35 | |
| 85018 | 122 | 121 | $715.93 | |
| 85014 | 122 | 121 | $715.93 | |
| J2001 | Injection, lidocaine hcl for intravenous infusion, 10 mg | 117 | 99 | $663.67 |
| 76642 | 12 | 12 | $653.59 | |
| J2795 | Injection, ropivacaine hydrochloride, 1 mg | 59 | 45 | $638.08 |
| 85652 | 136 | 123 | $617.63 | |
| J0735 | Injection, clonidine hydrochloride, 1 mg | 12 | 12 | $570.58 |
| 84156 | 84 | 68 | $552.00 | |
| 82378 | 74 | 63 | $492.51 | |
| 90837 | Psychotherapy, 53 minutes with patient | 20 | 12 | $359.70 |
| J2272 | Injection, morphine sulfate (fresenius kabi), not therapeutically equivalent to j2270, up to 10 mg | 75 | 69 | $357.68 |
| 85046 | 30 | 26 | $348.63 | |
| 83735 | 29 | 24 | $302.50 | |
| J7510 | Prednisolone oral, per 5 mg | 134 | 126 | $285.54 |
| J0131 | Injection, acetaminophen, not otherwise specified,10 mg | 16 | 13 | $223.80 |
| A4216 | Sterile water, saline and/or dextrose, diluent/flush, 10 ml | 19 | 12 | $159.30 |
| 82657 | 14 | 12 | $153.70 | |
| 83690 | 15 | 13 | $150.99 | |
| 84550 | 13 | 13 | $143.57 | |
| 82951 | 13 | 13 | $143.18 | |
| Q9967 | Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml | 46 | 44 | $127.35 |
| 77063 | Screening digital breast tomosynthesis, bilateral | 12 | 12 | $123.11 |
| 85045 | 17 | 13 | $80.14 | |
| S0020 | Injection, bupivicaine hydrochloride, 30 ml | 15 | 12 | $73.95 |
| 80143 | 13 | 13 | $43.69 | |
| 80179 | 13 | 13 | $43.69 | |
| 82952 | 12 | 12 | $43.62 | |
| 87077 | 12 | 12 | $43.17 | |
| 82077 | 13 | 13 | $40.48 | |
| G1004 | Clinical decision support mechanism national decision support company, as defined by the medicare appropriate use criteria program | 289 | 232 | $0.00 |